The Metabolic Architecture of Glaucoma: A Unified Framework of Cofactor Failure and Kynurenine Dysregulation
International Journal of Molecular Sciences · 12.05.2026 · 27 (10) · 4311
DOI: 10.3390/ijms27104311 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.05.2026. Verfasst von Liva Caikovska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Riga Stradins University, LV-1007 Riga, Latvia. Hauptthemen laut MEDLINE: Kynurenine, Glaucoma. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glaucoma remains a primary cause of blindness, yet its pathogenesis often extends beyond intraocular pressure (IOP). This review integrates four converging lines of metabolic evidence—aqueous humor (AH) metabolomics, kynurenine pathway (KP) activity, tetrahydrobiopterin (H4BIP) biology, and NAD/one-carbon dysfunction—into a testable framework for retinal ganglion cell vulnerability. By utilizing a systematic AH metabolomics atlas covering glaucoma, pseudoexfoliation, and diabetes on a standardized HILIC-LC-HRMS platform, we demonstrate that, while aromatic amino acid elevations are non-specific markers, kynurenine monooxygenase (KMO) upregulation is a condition-specific glaucoma signature. These local findings are corroborated by systemic evidence: POAG patients exhibit significant folic acid deficiency (p = 0.007) and elevated alpha-1-antitrypsin (AAT). Critically, AAT correlates inversely with both serum folate (rs = −0.485, p < 0.001) and retinal nerve fiber layer thickness (rs = −0.386, p = 0.017), providing the first in-patient evidence linking systemic inflammation to structural optic nerve damage. We conclude that KMO serves as a critical enzymatic node linking tryptophan metabolism, H4BIP availability, and NAD synthesis. These results characterize glaucoma as a disease of progressive cofactor failure and define a research agenda for multimodal metabolic neuroprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Riga Stradins University, LV-1007 Riga, Latvia.
- Clinic of Ophthalmology, Pauls Stradins Clinical University Hospital, LV-1002 Riga, Latvia.
- Institute of Biomaterials and Bioengineering, Faculty of Natural Sciences and Technology, Riga Technical University, LV-1048 Riga, Latvia.
ORCID-Profile: Liva Caikovska, Juris Vanags, Guna Laganovska, Arturs Zemitis
Zitieren
APA
Caikovska, L., Veitners, A., Lavrinovica, D., Vanags, J., Klavins, K., Laganovska, G., & Zemitis, A. (2026). The Metabolic Architecture of Glaucoma: A Unified Framework of Cofactor Failure and Kynurenine Dysregulation. International Journal of Molecular Sciences, 27(10), 4311. https://doi.org/10.3390/ijms27104311
Vancouver
Caikovska L, Veitners A, Lavrinovica D, Vanags J, Klavins K, Laganovska G, et al. The Metabolic Architecture of Glaucoma: A Unified Framework of Cofactor Failure and Kynurenine Dysregulation. International Journal of Molecular Sciences. 2026;27(10):4311. doi:10.3390/ijms27104311
BibTeX
@article{Caikovska2026,
author = {Caikovska, Liva and Veitners, Alberts and Lavrinovica, Diana and Vanags, Juris and Klavins, Kristaps and Laganovska, Guna and Zemitis, Arturs},
title = {The Metabolic Architecture of Glaucoma: A Unified Framework of Cofactor Failure and Kynurenine Dysregulation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4311},
doi = {10.3390/ijms27104311}
}
EUVIMED